GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week’s decision to trade more than $20 billion of assets with Swiss rival Novartis
via NYT > Business Day http://ift.tt/1iCfG1Z
via WordPress http://ift.tt/QZmjpx
No comments:
Post a Comment